Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $...
Organogenesis Holdings (NASDAQ:ORGO) raises FY2025 Net product revenue outlook from $480.000 million-$510.000 million to $500.0...
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $...
Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial ...
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...
BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ: ORGO) with a Buy and maintains $7 price target.
